Log in to save to my catalogue

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2636889461

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

About this item

Full title

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.e208-e220

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

According to the latest reports from WHO, the incidence of antibiotic-resistant bacterial infections is increasing worldwide, resulting in increased morbidity and mortality and a rising pressure on health-care systems. However, the development of new antibiotics is an expensive and time-consuming process, urging scientists to seek alternative antim...

Alternative Titles

Full title

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2636889461

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2636889461

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(21)00612-5

How to access this item